Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial (BLOOD, 2010)

(untitled) - Sive, J; Buck, G; Fielding, A; Lazarus, H; Litzow, MR; Luger, S; Marks, D; McMillan, A; Richards, S; Rowe, J; Tallman, MS; Goldstone, A